Join to View Full Profile
1725 W Harrison StSuite 1010Chicago, IL 60612
Phone+1 312-942-5904
Dr. Cobleigh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
Rush University Medical CenterResidency, Internal Medicine, 1977 - 1979- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1976
Rush Medical College of Rush University Medical CenterClass of 1975
Certifications & Licensure
IL State Medical License 1977 - 2029
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2015-2017
Clinical Trials
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer Start of enrollment: 1995 Oct 01
- Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer Start of enrollment: 2000 Nov 28
- Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Start of enrollment: 2002 Jan 29
Publications & Presentations
PubMed
- A prospective study of serum folate levels in patients with solid tumors treated with olaparib.Jamile Shammo, Laura Owczarzak, Nicole K Yun, Lois Winkelman, Sanjib Basu
The Oncologist. 2025-10-01 - 54 citationsEganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, ...Brenda C O'Connell, Charley Hubbard, Nora Zizlsperger, Donna Fitzgerald, Jeffrey L Kutok
Journal for Immunotherapy of Cancer. 2024-08-30 - 3 citationsComparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.Melody A Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J Hockenberry
Breast Cancer Research and Treatment. 2024-04-01
Journal Articles
- Can Chimerism Explain breast/ovarian Cancers in BRCA Non-Carriers from BRCA-Positive Families?Lydia Usha, Melody Cobleigh, PLoS One
Press Mentions
Dr. Janet Wolter, Oncologist and Cancer Researcher at Rush, DiesFebruary 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
